Results

Total Results: 5,430 records

Showing results for "opioid".
Users also searched for: opioid

4161. Completion of recommended tests and referrals in telehealth vs in-person visits. | PSNet
      psnet.ahrq.gov/issue/completion-recommended-tests-and-referrals-telehealth-vs-person-visits
      January 31, 2024 - July 13, 2022 Lessons learned in implementing a chronic opioid therapy management system

4162. Implementation of patient safety structures and processes in the patient-centered medical home. | PSNet
      psnet.ahrq.gov/issue/implementation-patient-safety-structures-and-processes-patient-centered-medical-home
      September 28, 2022 - Improving Diagnostic Safety and Quality April 26, 2023 Association between opioid

4163. Registered nurses' efforts to ensure safety for home-dwelling older patients. | PSNet
      psnet.ahrq.gov/issue/registered-nurses-efforts-ensure-safety-home-dwelling-older-patients
      July 19, 2019 - September 29, 2017 Guideline for opioid therapy and chronic noncancer pain.

4164. Safety in teletriage by nurses and physicians in the United States and Israel: narrative review and qualitative study. | PSNet
      psnet.ahrq.gov/issue/safety-teletriage-nurses-and-physicians-united-states-and-israel-narrative-review-and
      April 29, 2020 - November 9, 2022 The opioid crisis: origins, trends, policies, and the roles of pharmacists

4165. Medication errors and trainees: advice for learners and organizations. | PSNet
      psnet.ahrq.gov/issue/medication-errors-and-trainees-advice-learners-and-organizations
      April 10, 2019 - Download Citation Related Resources From the Same Author(s) The opioid

4166. Emergency medical services system changes reduce pediatric epinephrine dosing errors in the prehospital setting. | PSNet
      psnet.ahrq.gov/issue/emergency-medical-services-system-changes-reduce-pediatric-epinephrine-dosing-errors
      October 06, 2021 - June 28, 2023 Patient outcomes in dose reduction or discontinuation of long-term opioid

4167. Development of a research agenda to identify evidence-based strategies to improve physician wellness and reduce burnout. | PSNet
      psnet.ahrq.gov/issue/development-research-agenda-identify-evidence-based-strategies-improve-physician-wellness-and
      June 01, 2022 - February 8, 2018 Pain Management and Prescription Opioid-related Harms: Exploring the

4168. The quest to eliminate intrathecal vincristine errors: a 40-year journey. | PSNet
      psnet.ahrq.gov/issue/quest-eliminate-intrathecal-vincristine-errors-40-year-journey
      September 15, 2010 - September 20, 2011 A mixed-methods analysis of patient safety incidents involving opioid

4169. Psn-Pdf (pdf file)
      psnet.ahrq.gov/node/49606/psn-pdf
      August 01, 2010 - nausea and vomiting.(4) An epidural can provide excellent postoperative pain control, thereby lowering opioid

4170. Psn-Pdf (pdf file)
      psnet.ahrq.gov/node/846768/psn-pdf
      March 29, 2023 - obstruction.16 Respiratory depressant medications such as opioids should be administered sparingly, and non-opioid … The benefits of opioid free anesthesia and the precautions necessary when employing it.

4171. Final Progress Report: Patient Safety in Hospice Care (pdf file)
      www.ahrq.gov/sites/default/files/2024-10/smucker-report.pdf
      January 01, 2024 - D) Unintended overdose of an opioid administered by a family caregiver due to confusion or misunderstanding … of how to use concentrated oral opioid liquid preparations.

4172. Endotracheal Tube Fallout in a Patient with Severe Obesity During Eye Surgery. | PSNet
      psnet.ahrq.gov/web-mm/endotracheal-tube-fallout-patient-severe-obesity-during-eye-surgery
      January 29, 2021 - obstruction. 16 Respiratory depressant medications such as opioids should be administered sparingly, and non-opioid … The benefits of opioid free anesthesia and the precautions necessary when employing it.

4173. White Paper: Standardized Library of Lumbar Spondylolisthesis Outcome Measures (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/white-paper-lumbar-spondylolisthesis.pdf
      March 01, 2021 - adverse reaction being similar to the stated reason for the intervention (e.g., adverse reaction to opioid

4174. White Paper: Standardized Library of Lumbar Spondylolisthesis Outcome Measures (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/white-paper-lumbar-spondylolisthesis.pdf
      March 01, 2021 - adverse reaction being similar to the stated reason for the intervention (e.g., adverse reaction to opioid

4175. Bandemia as a Harbinger of Stercoral Colitis and Impending Perforation | PSNet
      psnet.ahrq.gov/web-mm/bandemia-harbinger-stercoral-colitis-and-impending-perforation
      November 25, 2020 - shaking” at home and being weak “like a ragdoll,” which he attributed to her long history of high dose opioid … review found that 70% of patients will have a history of constipation. 4 Constipation is due to chronic opioid

4176. Making Healthcare Safer III Report | PSNet
      psnet.ahrq.gov/perspective/making-healthcare-safer-iii-report
      March 30, 2020 - the strategic goals from the Department of Health and Human Services (HHS), including addressing the opioid … Testing for CDI, CDI surveillance, antimicrobial stewardship, opioid stewardship, all those areas were … I also appreciated the work we did around opioid-related harms. … Safety May 28, 2020 Perspective Antibiotic and Opioid

4177. NIAC & Project Team Bios | The Academy
      integrationacademy.ahrq.gov/about/academy-team/niac-bios
      June 01, 2022 - BHI Ecosystem Products Playbooks Medications for Opioid … AHRQ Initiatives EvidenceNOW: Managing Unhealthy Alcohol Use Opioid … Initiative Older Adult Opioid Initiative Other HHS Initiatives … He is also a member of Maine’s Opioid Clinical Advisory Group and Maine’s Governor has appointed him

4178. Cannabis-App-F1-F4-Tables-Surveillance-Report-2 0 0 (xls file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-f1-f4-tables-surveillance-report-2_0_0.xlsx
      October 08, 2025 - Race, Other % Pain Duration Measure (Mean, Median) Pain Duration, Months Psychiatric Comorbidity % Opioid … Previous treatment with weak opioid: 42 vs. 38 Previous treatment with strong opioid: 19 vs. 11 96 71 … : 4% (7/167) vs. 4% (7/172) Other opioid: 20% (33/167) vs. 18% (31/172) 339 339 THC 2.7 mg/CBD 2.5 mg … : 9 vs. 13 Opioid: 2 vs. 3 Strong opioid: 3 vs. 0 66 66 THC 2.7 mg/CBD 2.5 mg per 100 mcl oromucosal … Use (Mean Daily Dose [MDD]) Opioid Equivalents Assessment Time (Weeks) Variance Type for Opioid Use

4179. Cer-250-Cannabis-Tables-E1-E4-2022-Update 0 (xls file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-tables-e1-e4-2022-update_0.xlsx
      January 01, 2022 - Race, Other % Pain Duration Measure (Mean, Median) Pain Duration, Months Psychiatric Comorbidity % Opioid … Previous treatment with weak opioid: 42 vs. 38 Previous treatment with strong opioid: 19 vs. 11 96 71 … : 4% (7/167) vs. 4% (7/172) Other opioid: 20% (33/167) vs. 18% (31/172) 339 339 THC 2.7 mg/CBD 2.5 mg … : 9 vs. 13 Opioid: 2 vs. 3 Strong opioid: 3 vs. 0 66 66 THC 2.7 mg/CBD 2.5 mg per 100 mcl oromucosal … Use (Mean Daily Dose [MDD]) Opioid Equivalents Assessment Time (Weeks) Variance Type for Opioid Use

4180. Cannabis-2022-Update-Surv-Rep-1-App-F1-4 (xls file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-update-surv-rep-1-app-F1-4.xlsx
      January 01, 2022 - Race, Other % Pain Duration Measure (Mean, Median) Pain Duration, Months Psychiatric Comorbidity % Opioid … Previous treatment with weak opioid: 42 vs. 38 Previous treatment with strong opioid: 19 vs. 11 96 71 … : 4% (7/167) vs. 4% (7/172) Other opioid: 20% (33/167) vs. 18% (31/172) 339 339 THC 2.7 mg/CBD 2.5 mg … : 9 vs. 13 Opioid: 2 vs. 3 Strong opioid: 3 vs. 0 66 66 THC 2.7 mg/CBD 2.5 mg per 100 mcl oromucosal … Use (Mean Daily Dose [MDD]) Opioid Equivalents Assessment Time (Weeks) Variance Type for Opioid Use